Communications Medicine (Sep 2022)

Medication history-wide association studies for pharmacovigilance of pregnant patients

  • Anup P. Challa,
  • Xinnan Niu,
  • Etoi A. Garrison,
  • Sara L. Van Driest,
  • Lisa M. Bastarache,
  • Ethan S. Lippmann,
  • Robert R. Lavieri,
  • Jeffery A. Goldstein,
  • David M. Aronoff

DOI
https://doi.org/10.1038/s43856-022-00181-w
Journal volume & issue
Vol. 2, no. 1
pp. 1 – 10

Abstract

Read online

Challa et al. used 2.8 million electronic health records for proactive pharmacovigilance program development, by rapidly generating and validating hypotheses between medication use during pregnancy and neonatal neurodevelopmental defects. They identify five drug classes for which deeper safety signal evaluation may improve product marketing.